First Amendment to License AgreementLicense Agreement • September 20th, 2019 • AC Immune SA • Pharmaceutical preparations
Contract Type FiledSeptember 20th, 2019 Company IndustryThis First Amendment to License Agreement (the “Amendment”) is made and entered into as of September 19, 2019, by and between AC Immune SA, a Swiss Company (“ACI”) and Eli Lilly and Company, an Indiana Corporation (“Lilly”). (As used herein ACI and Lilly may be individually referred to as a “Party” and collectively referred to as the “Parties”).